Cellectar Biosciences Inc [NASDAQ: CLRB] price plunged by -0.18 percent to reach at $0.0.
The one-year CLRB stock forecast points to a potential upside of 95.06. The average equity rating for CLRB stock is currently 1.50, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Cellectar Biosciences Inc [CLRB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLRB shares is $5.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLRB stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Cellectar Biosciences Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 05, 2024. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on July 01, 2020, representing the official price target for Cellectar Biosciences Inc stock. Previously, the target price had yet another raise to $10, while ROTH Capital analysts kept a Buy rating on CLRB stock.
The Average True Range (ATR) for Cellectar Biosciences Inc is set at 0.07 The Price to Book ratio for the last quarter was 7.38, with the Price to Cash per share for the same quarter was set at 0.83.
CLRB Stock Performance Analysis:
Cellectar Biosciences Inc [CLRB] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -18.41. With this latest performance, CLRB shares dropped by -77.98% in over the last four-week period, additionally sinking by -88.86% over the last 6 months – not to mention a drop of -91.88% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLRB stock in for the last two-week period is set at 19.57, with the RSI for the last a single of trading hit 23.67, and the three-weeks RSI is set at 18.94 for Cellectar Biosciences Inc [CLRB]. The present Moving Average for the last 50 days of trading for this stock 1.1375, while it was recorded at 0.3134 for the last single week of trading, and 2.2533 for the last 200 days.
Insight into Cellectar Biosciences Inc Fundamentals:
Cellectar Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.77 and a Current Ratio set at 1.77.
Cellectar Biosciences Inc [CLRB] Institutonal Ownership Details
There are presently around $34.55%, or 35.56%% of CLRB stock, in the hands of institutional investors.
